晚期非血液系统恶性肿瘤的临床试验
总计2792个结果
-
Millennium Pharmaceuticals, Inc.完全的Advanced Non-hematologic Malignancies美国, 加拿大
-
Shanghai Yuyao Biotech Co., Ltd.招聘中
-
Novartis Pharmaceuticals完全的Cancer Patients With Advanced Solid Tumors Including Lymphoma or Chronic Hematological Malignancies美国
-
Centre Hospitalier Universitaire de BesanconCentre Hospitalier Universitaire Saint Antoine, Paris; Centre de Lutte Contre le Cancer Alexis... 和其他合作者完全的
-
Charite University, Berlin, GermanyUniversity of Leipzig未知
-
Millennium Pharmaceuticals, Inc.完全的
-
iOMEDICO AGBristol-Myers Squibb; Roche Pharma AG完全的
-
Anand B. Karnad完全的Advanced B-cell Lymphoid Malignancies美国
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Novartis Pharmaceuticals; Brigham...终止
-
AstraZenecaParexel主动,不招人
-
Tel-Aviv Sourasky Medical CenterMeir Medical Center; Max Planck Institute for Infection Biology未知
-
Astellas Pharma Global Development, Inc.终止非血液系统恶性肿瘤 | Pharmacokinetics of ASP9853美国
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.招聘中
-
Kite, A Gilead Company邀请报名
-
Medical College of Wisconsin完全的Malignancies, Hematologic美国
-
Baylor College of MedicineCenter for Cell and Gene Therapy, Baylor College of Medicine完全的
-
Centre Hospitalier Universitaire de Besancon终止
-
University of California, Davis完全的
-
CASI Pharmaceuticals, Inc.完全的
-
Institute of Hematology & Blood Diseases HospitalJuventas Cell Therapy Ltd.可用的
-
Shandong UniversityJuventas Cell Therapy Ltd.未知
-
Millennium Pharmaceuticals, Inc.完全的晚期转移性黑色素瘤 | Advanced Non-hematologic Malignancies美国
-
Wake Forest University Health Sciences完全的
-
He HuangGracell Biotechnology Ltd.尚未招聘
-
Baylor College of MedicineCenter for Cell and Gene Therapy, Baylor College of Medicine撤销淋巴血液系统恶性肿瘤 | 脐带血移植
-
Senti Biosciences招聘中反洗钱/材料数据表 | CD33 表达血液恶性肿瘤 | FLT3 表达血液恶性肿瘤美国, 澳大利亚
-
Centre Hospitalier Universitaire de Saint EtienneInstitut de Cancérologie de la Loire完全的
-
Pfizer主动,不招人